[en] AMPA receptor potentiators belonging to 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxides have been found to be of great interest as cognitive enhancers. Previous structure–activity relationships have demonstrated the importance for activity of the nature of the substituent at the 7-position of the heterocycle. This work aims to explore the impact on AMPA potentiation of the introduction of different aryl and aralkyl ester or aryl amide groups at the 7-position. The new synthesized compounds were evaluated as AMPA receptor potentiators by examining their effect on rat brain primary cell cultures on AMPA-evoked membrane depolarisation using fluorescent membrane potential dyes and on imaging-based plate reader. The most potent compound of this series was 2-methylphenyl 4-methyl- 3,4-dihydro-2H-1,2,4-benzothiadiazine-7-carboxylate 1,1-dioxide 16c which provoked a strong potentiation of AMPA current with a potency close to that reported for the best reference compounds of the benzothiadiazine class (i.e cyclothiazide). This work also revealed that only the ortho-substitution of the phenyl group of 1,2,4-benzothiadiazine-7-carboxylate esters provided potent AMPA receptor potentiators opening the way to further chemical exploration.
Research Center/Unit :
Laboratoire de Chimie Pharmaceutique, CIRM, Université de Liège Institut de recherches Servier
S. Maren and M. Baudry, Neurobiology of Learning and Memory, 1995, 63, 1-18.
E. Graindorge, P. Francotte, S. Boverie, P. de Tullio and B. Pirotte, Curr. Med. Chem., 2004, 4, 95-103.
M. Beal, Curr. Opin. Neurobiol., 1992, 2, 657-662.
G. Lynch, Curr. Opin. Pharmacol., 2004, 4, 4-11.
M. D. Black, A Review of Preclinical Data, Psychopharmacology., 2005, 179, 154-163.
P. Francotte, P. de Tullio, P. Fraikin, S. Counerotte, E. Goffin and B. Pirotte, Recent Pat. CNS Drug Discovery, 2006, 1, 239-246.
K. Partin, D. Patneau, C. Winters, M. Mayer and A. Buonanno, Neuron, 1993, 11, 1069-1082.
M. Bertolino, M. Baraldi, C. Parenti, D. Braghiroli, M. Di Bella, S. Vicini and E. Costa, Receptor Channel., 1993, 1, 267-278.
C. P. Ptak, A. H. Ahmed and R. E. Oswald, Biochemistry, 2009, 48, 8594-8602.
H. Hald, P. K. Ahring, D. B. Timmermann, T. Liljefors, M. Gajhede and J. S. Kastrup, J. Mol. Biol., 2009, 391, 906-917.
B. Pirotte, T. Podona, O. Diouf, P. de Tullio, P. Lebrun, L. Dupont, F. Somers, J. Delarge, P. Morain, P. Lestage, J. Lepagnol and M. Spedding, J. Med. Chem., 1998, 41, 2946-2959.
P. Francotte, P. de Tullio, T. Podona, O. Diouf, P. Fraikin, P. Lestage, L. Danober, J. Y. Thomas, D. H. Caignard and B. Pirotte, Bioorg. Med. Chem., 2008, 16, 9948-9956.
P. Lestage, L. Danober, B. Lockhart, A. Roger, C. Lebrun, J. L. Robin, P. Desos and A. Cordi, Res. Pract. Alzheimer's Dis., 2002, 6, 253-259.
P. Francotte, P. de Tullio, E. Goffin, G. Dintilhac, E. Graindorge, P. Fraikin, P. Lestage, L. Danober, J. Y. Thomas, D. H. Caignard and B. Pirotte, J. Med. Chem., 2007, 50, 3153-3157.
P. Francotte, E. Goffin, P. Frainkin, P. Lestage, J. C. Van Heugen, L. Danober, J. Y. Thomas, P. Chiap, D. H. Caignard, B. Pirotte and P. de Tullio, J. Med. Chem., 2010, 53, 1700-1711.
J. T. Chou and P. C. Jurs, Journal of Chemical Information and Modeling, 1979, 19, 172-178.
Y. Zhao, J. Jona, D. T. Chow, H. Rong, D. Semin, X. Xia, R. Zanon, C. Spancake and Ed. Maliski, Rapid Commun. Mass Spectrom., 2002, 16, 1548-1555.
C. F. Bigge and S. S. Nikam, Expert Opin. Ther. Pat., 1997, 7, 1099-1114.
J. J. Buccafusco, T. Weiser, K. Winter, K. Klinder and A. V. Terry Jr, Neuropharmacology, 2004, 46, 10-22.